🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/05/2012 | 7,84 | 7,87 | 7,64 | 7,82 | -0,16% | 3,02% | 199.894 |
| 30/05/2012 | 7,83 | 8,00 | 7,74 | 7,83 | -0,87% | 3,43% | 126.316 |
| 29/05/2012 | 8,05 | 8,12 | 7,83 | 7,90 | -1,63% | 3,56% | 127.278 |
| 25/05/2012 | 7,90 | 8,21 | 7,84 | 8,03 | +1,18% | 4,66% | 147.155 |
| 24/05/2012 | 7,19 | 8,10 | 7,12 | 7,94 | +10,70% | 13,53% | 519.212 |
| 23/05/2012 | 7,16 | 7,21 | 7,04 | 7,17 | -0,52% | 2,35% | 78.547 |
| 22/05/2012 | 7,33 | 7,34 | 7,14 | 7,21 | -1,70% | 2,81% | 182.742 |
| 21/05/2012 | 7,31 | 7,37 | 7,24 | 7,33 | +0,34% | 1,71% | 85.761 |
| 18/05/2012 | 7,32 | 7,34 | 6,99 | 7,31 | -0,26% | 4,77% | 310.020 |
| 17/05/2012 | 7,54 | 7,54 | 7,26 | 7,32 | -2,41% | 3,72% | 112.050 |
| 16/05/2012 | 7,56 | 7,61 | 7,47 | 7,50 | -0,74% | 1,81% | 51.456 |
| 15/05/2012 | 7,60 | 7,72 | 7,51 | 7,56 | -0,33% | 2,79% | 84.959 |
| 14/05/2012 | 7,60 | 7,76 | 7,59 | 7,59 | -1,54% | 2,30% | 70.051 |
| 11/05/2012 | 7,65 | 7,80 | 7,62 | 7,70 | -0,16% | 2,37% | 62.357 |
| 10/05/2012 | 7,77 | 7,79 | 7,62 | 7,72 | -0,32% | 2,17% | 51.296 |
| 09/05/2012 | 7,86 | 7,90 | 7,72 | 7,74 | -2,44% | 2,30% | 60.914 |
| 08/05/2012 | 7,60 | 7,99 | 7,57 | 7,94 | +3,58% | 5,50% | 159.338 |
| 07/05/2012 | 7,42 | 7,82 | 7,42 | 7,66 | +3,19% | 5,38% | 173.124 |
| 04/05/2012 | 7,51 | 7,62 | 7,39 | 7,42 | -1,81% | 3,07% | 201.016 |
| 03/05/2012 | 7,98 | 8,00 | 7,49 | 7,56 | -5,68% | 6,41% | 339.996 |
| 02/05/2012 | 7,56 | 8,07 | 7,49 | 8,02 | +2,15% | 7,67% | 448.519 |
| 01/05/2012 | 8,38 | 8,39 | 7,79 | 7,85 | -6,88% | 7,14% | 349.454 |
| 30/04/2012 | 8,64 | 8,68 | 8,39 | 8,43 | -2,74% | 3,39% | 107.401 |
| 27/04/2012 | 8,70 | 8,73 | 8,50 | 8,67 | -0,22% | 2,65% | 127.919 |
| 26/04/2012 | 8,81 | 8,83 | 8,67 | 8,68 | -1,35% | 1,91% | 67.807 |
| 25/04/2012 | 8,81 | 8,93 | 8,70 | 8,80 | +1,15% | 2,62% | 45.525 |
| 24/04/2012 | 8,62 | 8,73 | 8,58 | 8,70 | +0,79% | 1,81% | 115.256 |
| 23/04/2012 | 8,78 | 8,95 | 8,59 | 8,63 | -3,08% | 4,12% | 85.280 |
| 20/04/2012 | 8,92 | 9,05 | 8,77 | 8,91 | +1,64% | 3,08% | 100.027 |
| 19/04/2012 | 8,67 | 8,92 | 8,58 | 8,76 | +1,52% | 3,96% | 110.767 |